Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML

Bone Marrow Transplantation

Volumn 44, Issue 6, 2009, Pages 383-385

  Rokicka, M ^a   Styczynski, J ^b   Michalewska, B ^c   Torosian, T ^a   Tomaszewska, A ^a   Gronkowska, A ^a   Pogorzala, M ^b   Wysocki, M ^b   Lakomy, M ^c   Wiktor Jedrzejczak, W ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CD3 ANTIGEN; COMPLEMENT COMPONENT C3C; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYUREA; IMATINIB; IMMUNOGLOBULIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; THYMOCYTE ANTIBODY;

ACUTE BIPHENOTYPIC LEUKEMIA; ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD GROUP RHESUS SYSTEM; CASE REPORT; CD34 SELECTION; CHRONIC MYELOID LEUKEMIA; COOMBS TEST; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOGENETICS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HEMOLYSIS; HUMAN; INTERSTITIAL PNEUMONIA; MULTIPLE CYCLE TREATMENT; PLASMAPHERESIS; PRIORITY JOURNAL; SPLENECTOMY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MITIS;

ANEMIA, HEMOLYTIC; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, ANTI-IDIOTYPIC; ANTINEOPLASTIC AGENTS; BLOOD TRANSFUSION; CORD BLOOD STEM CELL TRANSPLANTATION; CYCLOSPORINE; DRUG RESISTANCE, NEOPLASM; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID, CHRONIC-PHASE; PIPERAZINES; PYRIMIDINES; SPLENECTOMY; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 70349608965     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.25     Document Type: Article

References (10)

1. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343-1347.
2. Weinreb S, Delgado JC, Clavijo OP, Yunis EJ, Bayer-Zwirello L, Polansky L et al. Transplantation of unrelated cord blood cells. Bone Marrow Transplant 1998; 22: 193-196.
3. Chen FE, Owen I, Savage D, Roberts I, Apperley J, Goldman JM et al Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997; 19: 491-495.
4. Drobyski WR, Potluri J, Sauer D, Gottschall JL. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1093-1099.
5. O'Brien TA, Eastlund T, Peters C, Neglia JP, Defor T, Ramsay NK et al Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: High incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 2004; 127: 67-75.
6. Dameshek W, Levine P. Isoimmunisation with Rh factor in acquired hemolytic anemia. N Engl J Med 1943; 228: 641-644.
7. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002; 42: 37-43.
8. Young PP, Uzieblo A, Trulock E, Lublin DM, Goodnough LT. Autoantibody formation after alloimmunization: Are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion 2004; 44: 67-72.
9. Radhi M, Rumelhart S, Tatman D, Goldman F. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: Significant improvement after treatment with rituximab. J Pediatr Hematol Oncol 2007; 29: 125-127.
10. Chao MM, Levine JE, Ferrara JL, Cooling L, Cooke KR, Hutchinson RJ et al. Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H. Pediatr Blood Cancer 2008; 50: 917-919.